Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have earned an average rating of “Hold” from the ten ratings firms that are presently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $16.8750.

OSCR has been the subject of several analyst reports. Stephens initiated coverage on Oscar Health in a research note on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price objective for the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. UBS Group restated a “neutral” rating and set a $15.00 price objective on shares of Oscar Health in a research note on Wednesday. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective on the stock in a report on Thursday. Finally, Barclays set a $18.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a report on Monday, January 5th.

Oscar Health Stock Down 2.2%

Oscar Health stock opened at $13.41 on Monday. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.80. The firm has a market capitalization of $3.55 billion, a price-to-earnings ratio of -7.70 and a beta of 1.90. The firm’s fifty day moving average price is $15.24 and its two-hundred day moving average price is $16.73. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last posted its earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 37.72% and a negative net margin of 3.79%.The business had revenue of $2.76 billion for the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the previous year, the firm earned ($0.62) earnings per share. The company’s revenue was up 17.3% on a year-over-year basis. On average, equities research analysts predict that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Mario Schlosser sold 76,962 shares of the business’s stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $17.01, for a total value of $1,309,123.62. Following the transaction, the insider owned 350,180 shares in the company, valued at $5,956,561.80. The trade was a 18.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Janet Liang sold 7,338 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the transaction, the insider directly owned 172,527 shares of the company’s stock, valued at approximately $2,862,222.93. This represents a 4.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 197,125 shares of company stock worth $3,265,300 in the last quarter. 25.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in shares of Oscar Health by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after purchasing an additional 540,851 shares during the period. Morgan Stanley increased its holdings in Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after buying an additional 2,043,758 shares during the last quarter. Thrive Capital Management LLC raised its position in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the period. BIT Capital GmbH boosted its stake in Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after acquiring an additional 5,227,152 shares during the last quarter. Finally, American Century Companies Inc. grew its position in shares of Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock valued at $100,298,000 after acquiring an additional 2,495,691 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.